Buprenorphine Tablet
Product Images NDC 0228-3153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 0228-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Buprenorphine HCl, Usp Has The Molecular Formula C29 H41 No4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol And Practically Insoluble In Cyclohexane. (Image 1)

FDA Label Image

Tablets Debossed (Image 2)

FDA Label Image

Tablets Debossed (Image 3)

FDA Label Image

Small Image (Image 4)

FDA Label Image

Principal Display Panel Ndc 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only (Image 5)

Principal Display Panel Ndc 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only (Image 5)
This is a medication guide for Buprenorphine Il sublingual tablets. The tablets are dispensed in a tight light-resistant container with a dosage of 2 mg of buprenorphine base. The usual dosage should be checked in the product information. The medicine guide should be given to each patient by the pharmacist. It also warns to keep the tablets out of reach of children as they will need emergency medical care if they accidentally take buprenorphine. The tablets must store at a temperature range of 25°C to 30°C. The tablets are manufactured by Teva Pharmaceuticals and are available as 30 tablets with a lot/exp below.*
FDA Label Image

Principal Display Panel Ndc 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only (Image 6)

Principal Display Panel Ndc 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only (Image 6)
Buprenorphine 1l Sublingual tablets with NDC0228-3153-03 is a prescription drug. Dispensing pharmacist should provide the medication guide to each patient. The drug is harmful if accidentally taken by children, so keep it out of reach. Each tablet contains Buprenorphine hydrochloride USP equivalent to 8 mg of buprenorphine base. It comes in a container that is light-resistant as defined in the USP. Store the drug at 25°C (77°F); excursions permitted o 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Teva Pharmaceuticals in Parsippany, Nj 07054, manufactures it. There is more information on the lot/exp date below.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.